Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Japanese launch for Viread

April 13, 2004

New HIV protease inhibitors designed by Tibotec scientists

April 8, 2004

DSMB recommends dosing of final patients in VRX-496 phase I trial

April 7, 2004

Completion of pilot study of Resurgex in immunocompromised patients

April 5, 2004

MIV-150/Carraguard microbicide demonstrates encouraging preclinical results

April 2, 2004

Remune selected for new Canadian HIV trial

April 1, 2004

Substituted phenylindoles for treatment of HIV disclosed in recent patent

March 31, 2004

International Partnership for Microbicides to develop Tibotec's TMC-120

March 31, 2004

Evotec and Panacos enter HIV medicinal chemistry collaboration

March 31, 2004

Telzir receives positive opinion in Europe

March 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...